Impact of a Nutrition Protocol on Vitamin D Supplementation in a Pediatric Intensive Care Unit: A Retrospective

Maria Pérez Marin1, Vivianne Chanez1, Guillaume Maitre1

  • 1Pediatric Intensive Care Unit, Service of Paediatrics, Women-Mother-Children Department, Lausanne University Hospital, Rue Du Bugnon 21, 1011 Lausanne, Switzerland.

Clinics and Practice
|October 28, 2025
PubMed

Insights

A new nutrition protocol (NP) improved vitamin D supplementation for critically ill children. While more patients received vitamin D, doses for older children and specific formulations presented challenges.

Area of Science:

  • Pediatric Critical Care Medicine
  • Nutritional Support
  • Endocrinology

Background:

  • Vitamin D deficiency (VDD) is common in pediatric intensive care unit (PICU) patients.
  • No universal guidelines exist for vitamin D supplementation in PICU settings.

Purpose of the Study:

  • To evaluate changes in vitamin D supplementation practices.
  • To compare practices before and after implementing a nutrition protocol (NP).

Main Methods:

  • Retrospective analysis of vitamin D administration in children (0-16 years) admitted to a PICU.
  • Data collected included timing, dosage, and adherence to guidelines.
  • Comparison made between the year before and the year after NP introduction.

Main Results:

  • Vitamin D supplementation increased significantly post-NP implementation (95 IU/day more).
  • Higher patient participation (95% vs. 77%) and adherence to NP recommendations for younger children.
  • Supplementation remained below recommended levels for children over one year old.

Conclusions:

  • Implementing a NP substantially improved vitamin D supplementation scope in PICU.
  • Challenges remain in meeting recommended vitamin D requirements due to formulation limitations.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240